{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:03:12Z","timestamp":1767650592303},"reference-count":142,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jgyn.2008.06.013","type":"journal-article","created":{"date-parts":[[2008,9,28]],"date-time":"2008-09-28T08:20:03Z","timestamp":1222590003000},"page":"637-660","source":"Crossref","is-referenced-by-count":14,"title":["Mise au point sur la contraception progestative"],"prefix":"10.1016","volume":"37","author":[{"given":"P.","family":"Madelenat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2008.06.013_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0010-7824(81)90091-3","article-title":"Effects of steroids on the in vitro forward migration of human spermatozoa","volume":"24","author":"Cheng","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib2","first-page":"295","article-title":"Contraceptive treatment with chlormadinone and its effect on the endometrium: a histological investigation","volume":"59","author":"K\u00fchne","year":"1972","journal-title":"Endokrinologie"},{"key":"10.1016\/j.jgyn.2008.06.013_bib3","first-page":"75","article-title":"Contraception with low dose chlormadinone acetate: clinical and histological results","volume":"2","author":"K\u00fchne","year":"1970","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.jgyn.2008.06.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(87)90057-6","article-title":"Endometrial morphological changes in IUD users: a review","volume":"36","author":"Sheppard","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.contraception.2004.07.002","article-title":"Endometrial vascularization in Levonorgestrel intrauterine device users; computerized microvessel measurement sudy","volume":"71","author":"Jondet","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib6","first-page":"277","article-title":"Action de la promegestone \u00e0 la dose de 0,500mg\/j vingt jours par mois sur le pic ovulatoire de LH","volume":"3","author":"Blacker","year":"1986","journal-title":"Hormones, Reproduc, Metab"},{"key":"10.1016\/j.jgyn.2008.06.013_bib7","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.84.11.4191","article-title":"The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women","volume":"84","author":"Couzinet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2008.06.013_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/oxfordjournals.humrep.a019245","article-title":"Ovarian activity and vaginal bleeding patterns with a desogestrel-only preparation at three different doses","volume":"11","author":"Rice","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2004.07.016","article-title":"Maintenance of ovulation inhibition with the 75 micrograms desogestrel-only contraceptive pill (Cerazette\u00ae) after scheduled 1\u00e9-h delays in tablet intake","volume":"71","author":"Korver","year":"2005","journal-title":"Contracepion"},{"key":"10.1016\/j.jgyn.2008.06.013_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"A comparison of the inhibition of ovulation achieved by desogestrel 75micrograms and levonorgestrel 30micrograms daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0010-7824(76)90004-4","article-title":"The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound","volume":"14","author":"Skouby","year":"1976","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib12","first-page":"79","article-title":"Administration prolong\u00e9e d\u2019ac\u00e9tate de Chlormadinone. Effets m\u00e9taboliques, tensionnels et hormonaux","volume":"42","author":"P\u00e9lissier","year":"1991","journal-title":"Gyn\u00e9cologie"},{"key":"10.1016\/j.jgyn.2008.06.013_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gyobfe.2004.12.002","article-title":"Activit\u00e9 antigonadotrope de l\u2019ac\u00e9tate de chlormadinone chez la femme en p\u00e9riode d\u2019activit\u00e9 g\u00e9nitale","volume":"33","author":"Chassard","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2008.06.013_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1297-9589(02)00009-7","article-title":"Propri\u00e9t\u00e9s antigonadotropes d\u2019un progestatif norpr\u00e9gnane\u00a0: l\u2019exemple du nom\u00e9gestrol ac\u00e9tate","volume":"31","author":"Jamin","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2008.06.013_bib15","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.contraception.2006.12.004","article-title":"Cochrane systematic reviews of IUD trials: lessons learned","volume":"75","author":"Grimes","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib16","unstructured":"French R, Van Vliet H, Cowan F et al. Hormonally impregnated intrauterine systemes (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. CD001776."},{"key":"10.1016\/j.jgyn.2008.06.013_bib17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/humrep\/del208","article-title":"Risk factors for IUD failure: results of a large multicentre case-control study","volume":"21","author":"Thonneau","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajog.2007.10.787","article-title":"Contraceptive efficacy of intrauterine devices. javascript:AL_get(this, \u2018jour\u2019, \u2018Am J Obstet Gynecol.\u2019)","volume":"198","author":"Thonneau","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib19","doi-asserted-by":"crossref","unstructured":"ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107: 1453-72.","DOI":"10.1097\/00006250-200606000-00055"},{"key":"10.1016\/j.jgyn.2008.06.013_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jgyn.2008.06.013_bib21","unstructured":"British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary-BNF40, September 2000."},{"key":"10.1016\/j.jgyn.2008.06.013_bib22","first-page":"149","article-title":"New aspects on the mechanism of action of contraceptive steroids: recent pharmacokinetic studies of low dose formulations","author":"Kuhl","year":"1991","journal-title":"Adv Contracept"},{"key":"10.1016\/j.jgyn.2008.06.013_bib23","doi-asserted-by":"crossref","unstructured":"Clinical pharmacokinetics of contraceptive steroids. An update.Shenfield GM, Griffin JM. Clin Pharmacokinet 1991 20: 15\u201337.","DOI":"10.2165\/00003088-199120010-00002"},{"key":"10.1016\/j.jgyn.2008.06.013_bib24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1212\/WNL.46.6.1534","article-title":"Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians","volume":"46","author":"Krauss","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jgyn.2008.06.013_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00009-8","article-title":"Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill. A literature review","volume":"59","author":"Weaver","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02211792","article-title":"The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome","volume":"12","author":"Levy","year":"1995","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jgyn.2008.06.013_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1783\/147118907782101724","article-title":"Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz","volume":"33","author":"Matiluko","year":"2007","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.jgyn.2008.06.013_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/aje\/kwi286","article-title":"The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen\/Progestin Interventions Mammographic Density Study","volume":"162","author":"Greendale","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib29","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/bmj.290.6482.1617","article-title":"Progesterone and the premenstrual syndrome: a double blind crossover trial","volume":"290","author":"Dennerstein","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jgyn.2008.06.013_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(85)92506-1","article-title":"Clinical experience of drug treatments for mastalgia","volume":"2","author":"Pye","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2008.06.013_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00672829","article-title":"Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol","volume":"225","author":"Colin","year":"1978","journal-title":"Arch Gynakol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib32","first-page":"71","article-title":"A randomised controlled trial of medroxyprogesterone acetate in mastalgia","volume":"72","author":"Maddox","year":"1990","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.jgyn.2008.06.013_bib33","unstructured":"Lavieille F. Actualit\u00e9s reproduction humaine 1998; vol 6, no\u00a01."},{"key":"10.1016\/j.jgyn.2008.06.013_bib34","first-page":"596","article-title":"Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study","volume":"184","author":"Euhus","year":"1997","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jgyn.2008.06.013_bib35","first-page":"19","article-title":"L\u2019ac\u00e9tate de nom\u00e9gestrol dans le traitement des mastopathies b\u00e9nignes","volume":"6","author":"Pons","year":"1996","journal-title":"R\u00e9sultats d\u2019un essai contr\u00f4l\u00e9. Le Sein"},{"key":"10.1016\/j.jgyn.2008.06.013_bib36","unstructured":"Plu-Bureau G, Thalabard JC. Les progestatifs en canc\u00e9rologie mammaire. Progestatifs et cancer du sein\u00a0: donn\u00e9es \u00e9pid\u00e9miologiques. 28es journ\u00e9es de la SFSPM. Lille, novembre 2006."},{"key":"10.1016\/j.jgyn.2008.06.013_bib37","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713\u201327.","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"10.1016\/j.jgyn.2008.06.013_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.11167","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib39","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women\u2019s Lifestyle and Health Cohort Study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jgyn.2008.06.013_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1525-1500.1999.99032.x","article-title":"Percutaneous progesterone use and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease","volume":"23","author":"Plu-Bureau","year":"1999","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.jgyn.2008.06.013_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1994.291","article-title":"Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease","volume":"70","author":"Plu-Bureau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6603618","article-title":"Oral progestagens before menopause and breast cancer risk","volume":"96","author":"Fabre","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.contraception.2003.12.015","article-title":"Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer","volume":"69","author":"Strom","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-7824(01)00188-3","article-title":"Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health. International Collaborative Post Marketing Surveillance","volume":"63","author":"Meirik","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/bjc.1989.288","article-title":"Oral contraceptives and breast cancer: results from an expanded case-control study","volume":"60","author":"Stanford","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib48","unstructured":"Oral contraceptives and breast cancer. IPPF Med Bull 1989; 23: 3."},{"key":"10.1016\/j.jgyn.2008.06.013_bib49","first-page":"219","article-title":"Identification et prise en charge des pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers du sein et de l\u2019ovaire (mise \u00e0 jour 2004)","volume":"91","author":"Eisinger","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib50","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral Contraceptives and Breast Cancer Risk in the International BRCA1\/2 Carrier Cohort Study: A Report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib51","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. Lancet 2008; 371: 303\u201314.","DOI":"10.1016\/S0140-6736(08)60167-1"},{"key":"10.1016\/j.jgyn.2008.06.013_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2008.06.013_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s001980170155","article-title":"The impact of lifestyle factors on stress fractures in female Army recruits","volume":"12","author":"Lappe","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jgyn.2008.06.013_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","article-title":"Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception","volume":"15","author":"Beerthuizen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0306-5456(01)00296-0","article-title":"Overview of the relationship between use of progestogen-only contraceptives and bone mineral density","volume":"108","author":"Banks","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2008.06.013_bib57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib58","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2004.04.064","article-title":"Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate","volume":"82","author":"Clark","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bmj.308.6923.247","article-title":"Recovery of bone density in women who stop using medroxyprogesterone acetate","volume":"308","author":"Cundy","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2008.06.013_bib60","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/bmj.308.6943.1567a","article-title":"Depot medroxyprogesterone and bone density","volume":"308","author":"Cundy","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2008.06.013_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jgyn.2008.06.013_bib62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jadohealth.2006.03.011","article-title":"Depot medroxyprogesterone acetate and bone mineral density in adolescents-the Black Box Warning: a Position Paper of the Society for Adolescent Medicine","volume":"39","author":"Cromer","year":"2006","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jgyn.2008.06.013_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-7824(95)00121-P","article-title":"Differential effects on bone density of progestogen-only methods for contraception in premenopausal women","volume":"52","author":"Naessen","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib64","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib65","first-page":"411","article-title":"Tol\u00e9rance biologique et clinique du Nom\u00e9gestrol ac\u00e9tate, administ\u00e9 seul puis associ\u00e9 en s\u00e9quentiel invers\u00e9 au 17\u03b2 estradiol cutan\u00e9, chez des femmes \u00e0 risque pr\u00e9sentant une dyslipoprot\u00e9in\u00e9mie de type II a","volume":"59","author":"Zartarian","year":"1998","journal-title":"Annales d\u2019Endocrinologie"},{"key":"10.1016\/j.jgyn.2008.06.013_bib66","first-page":"45","article-title":"Contraception progestative par l\u2019ac\u00e9tate de chlormadinone chez les femmes \u00e0 risques vasculaires","volume":"15","author":"Pelissier","year":"1987","journal-title":"Contracept Fertil Sex (Paris)"},{"key":"10.1016\/j.jgyn.2008.06.013_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestogens on haemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.jgyn.2008.06.013_bib68","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2008.06.013_bib69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/j.1600-0412.1999.780515.x","article-title":"The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1","volume":"78","author":"Pakarinen","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2008.06.013_bib70","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestogens on actived protein (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jgyn.2008.06.013_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effect of second- and third-generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jgyn.2008.06.013_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75microgram desogestrel or 30microgram levonorgestrel","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91524-1","article-title":"Antithrombin III and oral contraception with progestagen-only preparation","volume":"2","author":"Conard","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2008.06.013_bib74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1646734","article-title":"The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy","volume":"39","author":"Bounameaux","year":"1978","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jgyn.2008.06.013_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0010-7824(95)00144-1","article-title":"The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women","volume":"52","author":"Barbosa","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib76","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/humrep\/dem153","article-title":"Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade","volume":"22","author":"Vieira","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib77","doi-asserted-by":"crossref","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 1998; 57: 315\u201324.","DOI":"10.1016\/S0010-7824(98)00041-9"},{"key":"10.1016\/j.jgyn.2008.06.013_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jgyn.2008.06.013_bib79","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jgyn.2008.06.013_bib80","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1210\/jc.84.6.1862","article-title":"Hypertension in women","volume":"84","author":"August","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2008.06.013_bib81","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/bmj.285.6339.403","article-title":"Blood pressure and contraceptive use","volume":"285","author":"Khaw","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jgyn.2008.06.013_bib82","first-page":"531","article-title":"Contraception par la progesterone en continu chez les femmes hypertendues","volume":"30","author":"Millet","year":"1979","journal-title":"Gyn\u00e9cologie"},{"key":"10.1016\/j.jgyn.2008.06.013_bib83","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9378(72)90811-3","article-title":"The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure","volume":"112","author":"Spellacy","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib84","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-39-5-882","article-title":"Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man","volume":"39","author":"Oelkers","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2008.06.013_bib85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib86","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2008.06.013_bib87","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0248-8663(85)80036-9","article-title":"Hormones et lupus","volume":"6","author":"Gompel","year":"1985","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.jgyn.2008.06.013_bib88","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2008.06.013_bib89","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203307078074","article-title":"Contraception in adolescents with systemic lupus erythematosus","volume":"16","author":"Tincani","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jgyn.2008.06.013_bib90","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780250603","article-title":"Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus","volume":"25","author":"Jungers","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jgyn.2008.06.013_bib91","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1016\/S0002-9378(99)70694-0","article-title":"Benefits and risks of oral contraceptives","volume":"180","author":"Sherif","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib92","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jgyn.2008.06.013_bib93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/10091145","article-title":"Oxidative stress, lipid profile and liver functions in average egyptian long term depo medroxy progesterone acetate (DMPA) users","volume":"10","author":"Faddah","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.jgyn.2008.06.013_bib94","first-page":"401","article-title":"Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes","volume":"41","author":"Westhoff","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jgyn.2008.06.013_bib95","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/0002-9378(93)90330-L","article-title":"Selectivity information on desogestrel","volume":"168","author":"Collins","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib96","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.2007.03046.x","article-title":"Effects of the progestagen-only contraceptive implant Implanon(R) on cardiovascular risk factors","volume":"68","author":"Merki-Feld","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jgyn.2008.06.013_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006133.pub2","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2008.06.013_bib98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0010-7824(91)90014-7","article-title":"Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone","volume":"44","author":"Ball","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib99","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/j.1600-0412.1999.780810.x","article-title":"Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use","volume":"78","author":"Ronnerdag","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2008.06.013_bib100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)46817-2","article-title":"Two years\u2019 experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study","volume":"39","author":"Nilsson","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(99)00053-0","article-title":"A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant","volume":"60","author":"Zheng","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/ejc.6.2.71.77","article-title":"The effects of two progrestogen-only pills containing either desogestrel (75microgram\/day) or levonorgestrel (30microgram\/day) on carbohydrate metabolism and adrenal and thyroid function","volume":"6","author":"Kivela","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jgyn.2008.06.013_bib103","series-title":"Contraception","first-page":"397","article-title":"Connectivites et Contraception","author":"Gompel","year":"2007"},{"key":"10.1016\/j.jgyn.2008.06.013_bib104","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1016\/S0010-7824(98)00122-X","article-title":"An integrated analysis of nonmenstrual adverse events with Implanon","volume":"58","author":"Urbancsek","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib105","doi-asserted-by":"crossref","unstructured":"Darney P, Patel A, Rosen K, Shapiro L, Kaunitz A. Safety and efficacy of a single-rod etonogestrel implant (Implanon\u00ae): results from 11 international clinical trials. Fertility and Sterility 2008: \u201cin press\u201d.","DOI":"10.1016\/j.fertnstert.2008.02.140"},{"key":"10.1016\/j.jgyn.2008.06.013_bib106","first-page":"97","article-title":"Clinical pharmacology of the steroidal oral contraceptives","volume":"24","author":"Durand","year":"1979","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.jgyn.2008.06.013_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2007.10.004","article-title":"The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow","author":"Jim\u00e9nez","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib108","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(96)00179-5","article-title":"Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses","volume":"54","author":"Alvarez","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib109","doi-asserted-by":"crossref","unstructured":"ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Hum Reprod 2001; 16: 1527\u201335.","DOI":"10.1093\/humrep\/16.7.1527"},{"key":"10.1016\/j.jgyn.2008.06.013_bib110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jgyn.2008.06.013_bib111","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib112","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2004.06.010","article-title":"Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women","volume":"70","author":"Li","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib113","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/14740338.2.3.321","article-title":"Risk-benefit effects of implantable contraceptives in women","volume":"2","author":"Brache","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jgyn.2008.06.013_bib115","first-page":"69","article-title":"Effects of nomegestrol acetate administered alone or with cutaneous 17 beta estradiol in inversed sequence on cycle quality and hot flashes in periomenopausal women","volume":"26","author":"Zartarian","year":"1998","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.jgyn.2008.06.013_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001141.pub3","article-title":"Support for breastfeeding mothers","author":"Britton","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2008.06.013_bib117","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0306-5456(01)00239-X","article-title":"Comparative study of the effects of a progestogen-only pill containing desogestrel and an intra uterine contraceptive device in lactating women","volume":"108","author":"Bjarnad\u00f3ttir","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001777.pub2","article-title":"Immediate postabortal insertion of intrauterine devices","author":"Grimes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2008.06.013_bib119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/713605429","article-title":"Meningioma and hormonal influences","volume":"6","author":"Wahab","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.jgyn.2008.06.013_bib120","unstructured":"WHO. Medical Eligibility Criteria for Contraceptive Use. 3eme edition, WHO 2004."},{"key":"10.1016\/j.jgyn.2008.06.013_bib121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1479-828X.2007.00727.x","article-title":"Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis","volume":"47","author":"Al-Jefout","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib122","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1783\/0000000052972799","article-title":"Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon)","volume":"31","author":"Yisa","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.jgyn.2008.06.013_bib123","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(00)01759-3","article-title":"Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis","volume":"75","author":"Fedele","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(99)00291-5","article-title":"A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study","volume":"72","author":"Vercellini","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/humrep\/deh650","article-title":"The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3-year follow-up","volume":"20","author":"Lockhat","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib126","unstructured":"Afssaps. Recommendations of good practice: drug therapy for fibroma of uterus. Gynecol Obstet Fertil 2005; 33(7-8): 547\u201352."},{"key":"10.1016\/j.jgyn.2008.06.013_bib127","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.contraception.2006.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea","volume":"75","author":"Bahamondes","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib128","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0015-0282(97)00245-8","article-title":"Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device","volume":"68","author":"Fedele","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2008.06.013_bib129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2008.06.013_bib130","first-page":"536","article-title":"Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis","volume":"40","author":"He","year":"2005","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.jgyn.2008.06.013_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib132","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women","volume":"114","author":"Chan","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2008.06.013_bib133","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(00)03197-4","article-title":"Local levonorgestrel to prevent tamoxifen-related endometrial lesions","volume":"356","author":"Neven","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2008.06.013_bib134","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jnnp.55.6.486","article-title":"Mifepristone (RU 486) treatment of meningiomas","volume":"55","author":"Lamberts","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jgyn.2008.06.013_bib135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-6-152","article-title":"Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study","volume":"6","author":"Custer","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgyn.2008.06.013_bib136","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3171\/jns.2004.100.2.0328","article-title":"Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report","volume":"100","author":"Gruber","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jgyn.2008.06.013_bib137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-199614010-00004","article-title":"Cyproterone acetate: is it hepato- or genotoxic?","volume":"14","author":"Rabe","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.jgyn.2008.06.013_bib138","first-page":"373","article-title":"Facteurs de risque de la grossesse extra-ut\u00e9rine: \u00e9tude cas t\u00e9moins dans 7 maternit\u00e9s de la r\u00e9gion parisienne","volume":"20","author":"Fernandez","year":"1991","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2008.06.013_bib139","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajog.2003.07.021","article-title":"Pregnancy during the use of levonorgestrel intrauterine system","volume":"190","author":"Backman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2008.06.013_bib140","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gyobfe.2005.10.016","article-title":"Le r\u00e9seau des centres r\u00e9gionaux de pharmacovigilance. Implanon\u00ae: difficult\u00e9s d\u2019insertion et de retrait, \u00e9checs contraceptifs","volume":"33","author":"Bensouda-Grimaldi","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2008.06.013_bib141","doi-asserted-by":"crossref","unstructured":"World Health Organization Collaborative Study of Cardiovascular and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. J Clin Epidemiol 1995; 48: 1513\u201347.","DOI":"10.1016\/0895-4356(95)00516-1"},{"key":"10.1016\/j.jgyn.2008.06.013_bib142","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231508002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231508002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T11:54:52Z","timestamp":1631879692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231508002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":142,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0368231508002676"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2008.06.013","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}